- Home
- PSF vs SOPH Comparison
PSF vs SOPH Comparison
Compare PSF & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSF
- SOPH
- Stock Information
- Founded
- PSF 2010
- SOPH 2011
- Country
- PSF United States
- SOPH Switzerland
- Employees
- PSF N/A
- SOPH 423
- Industry
- PSF Investment Managers
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PSF Finance
- SOPH Health Care
- Exchange
- PSF Nasdaq
- SOPH Nasdaq
- Market Cap
- PSF 235.2M
- SOPH 193.8M
- IPO Year
- PSF N/A
- SOPH 2021
- Fundamental
- Price
- PSF $19.53
- SOPH $3.00
- Analyst Decision
- PSF
- SOPH Strong Buy
- Analyst Count
- PSF 0
- SOPH 2
- Target Price
- PSF N/A
- SOPH $6.50
- AVG Volume (30 Days)
- PSF 25.0K
- SOPH 24.1K
- Earning Date
- PSF 01-01-0001
- SOPH 05-06-2025
- Dividend Yield
- PSF 7.69%
- SOPH N/A
- EPS Growth
- PSF N/A
- SOPH N/A
- EPS
- PSF N/A
- SOPH N/A
- Revenue
- PSF N/A
- SOPH $67,173,000.00
- Revenue This Year
- PSF N/A
- SOPH $15.88
- Revenue Next Year
- PSF N/A
- SOPH $24.07
- P/E Ratio
- PSF N/A
- SOPH N/A
- Revenue Growth
- PSF N/A
- SOPH 4.66
- 52 Week Low
- PSF $16.00
- SOPH $2.58
- 52 Week High
- PSF $20.19
- SOPH $5.63
- Technical
- Relative Strength Index (RSI)
- PSF 55.16
- SOPH 51.16
- Support Level
- PSF $19.10
- SOPH $2.82
- Resistance Level
- PSF $19.51
- SOPH $3.10
- Average True Range (ATR)
- PSF 0.16
- SOPH 0.19
- MACD
- PSF 0.00
- SOPH -0.00
- Stochastic Oscillator
- PSF 72.88
- SOPH 42.22
About PSF Cohen & Steers Select Preferred and Income Fund Inc.
Cohen & Steers Select Preferred and Income Fund Inc is a diversified, closed-end investment company. The Fund's primary investment objective is high current income with capital appreciation as its secondary objective. The Fund invests at least of its Managed Assets in preferred and other income securities issued by U.S. and non-U.S. companies.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.